ArticleFrontiers in oncology2021

Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients.

Yawei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.